A device allowing the creation of an alimentary bolus flow between two stomas, including means forming a pump; first/second sealed connection means capable of connecting the suction opening to an upstream/downstream stoma located on the abdominal wall of a patient; and first and/or second anti-reflux means. The first and/or second anti-reflux means includes a cavity into which the alimentary bolus passes, an inflatable balloon mounted in the cavity and means for inflating the balloon, that make it possible to modify the inflation of the latter, and the balloon is shaped to shift from an open position in which the balloon is partially inflated and has a neck allowing the passage of the alimentary bolus, to a closed position in which the balloon is more inflated than in the open position and in which the balloon is in contact with the wall of the cavity and the neck is sealed as a result of the portion of the wall of the balloon defining the neck being compressed against itself, at least over a portion of the height of the neck.

Systems, methods, and other embodiments associated with organism medical treatment are described. In one embodiment, a system can comprise a collection component configured to receive a medical control instruction. The medical control instruction can be based, at least in part, on an organism medical information set for an organism. The system can further comprise a regulation component configured to control administration of a treatment to the organism. The regulation component can control the administration of the treatment to the organism based, at least in part, on the medical control instruction.

In one aspect, the present disclosure provides a collar for securement to a barrel of a syringe, the barrel having an outer diameter and a flange extending from the outer diameter. The collar may include a distal opening with an inner diameter configured to surround the outer diameter of the barrel, a collar flange located proximal the distal opening and having a length and a thickness greater than a length and a thickness of the flange of the barrel, and a flange-receiving cavity extending at least partially within the collar flange and configured to receive the flange of the barrel.

Various aspects of the present disclosure are directed toward medical devices, systems, and methods. The medical devices may include a portion having a radially expansive force greater than a radially expansive force other portions of the device. In addition, the medical device may include one or more constraining mechanisms for deployment of the medical devices.

An endoscopic apparatus including a probe which is introduced into, for example, the intestinal tract of a living organism and which operates therein, adapted to perform one or more functions. In one embodiment, the probe communicates wirelessly with a portable electronic device outside the organism, the portable device which acts to relay data between the probe and a remote networked entity. In one variant, the probe includes an accelerometer to, for example, wake the probe up from a sleep mode when the organism is awake or ambulatory.

In some embodiments, an apparatus includes a first catheter movably disposed within a first lumen of a second catheter. The first catheter has a first occlusion member disposed at a distal end portion and the second catheter has a second occlusion member disposed at a distal end portion. A third catheter has a third occlusion member disposed at a distal end portion and is moveably disposable within a second lumen of the second catheter. The second catheter has a side port in fluid communication with the second lumen and the third catheter can be extended out of the second lumen through the side port. The first occlusion member, second occlusion member and third occlusion member can collectively isolate a target region including a portion of a first body lumen (e.g., a main vessel) and a portion of a second body lumen (e.g., a branch of the main vessel).

A capsule device (100), comprising: a) a capsule housing (110, 120) having proximal and distal ends and defining a main axis, the capsule housing comprising a plurality of retainer portions (113a) distributed around the main axis, and b) an actuation mechanism (140, 150) operable between a pre-actuation configuration and an actuating configuration, wherein the actuation mechanism (140, 150) comprises: b1) an actuation member (150) configured for axial distal movement, the actuation member (150) comprising a base portion (151) and a plurality of radially deflectable latch arms (153) extending proximally therefrom, wherein each latch arm (153) defines a radially inwards facing latch surface (153b) being inclined with respect to the axis and a radially outwards facing latch surface (153a) in retaining engagement with a respective retainer portion (113a) of the capsule housing (110, 120), b2) a drive spring (140) exerting mechanical load onto the actuation member (150) for driving the actuation member axially in the distal direction, and b3) a dissolvable latch support (160) having radially outwards facing surfaces (163b) being inclined relative to the axis, wherein the dissolvable latch support (160) is arranged centrally on-axis and wherein the plurality of radially deflectable latch arms (163) are distributed around the main axis so that each latch arm (163) is releasably retained radially between a respective one of said inclined outwards facing surfaces (163b) of the dissolvable latch support (160) and a respective one the retainer portions (113a).

A device and a method for delivering a flowable ingestible medicament into the gastrointestinal tract of a user. The device includes a vibrating ingestible capsule attached to a medicament delivery compartment. The medicament delivery compartment includes a housing including a portal, a medicament reservoir, a reservoir biasing mechanism applying pressure to the reservoir, a resilient conduit extending from the reservoir to the portal, and a valve including a weight and a spring adapted, when closed, to bias the weight against the conduit so as to block flow therethrough, and, when open, to remove the weight from the conduit to allow fluid to flow through the conduit. When the vibrating agitator is in the vibration mode of operation, vibrations exerted thereby are applied to the valve biasing mechanism and periodically transition the valve between the closed operative orientation and the open operative orientation.

The present invention generally relates to the controlled administration of substances through infusion devices implanted in the human body and more particularly has as an object an improved system for the controlled administration of a substance such as a drug, a hormone or a hormone complex and the like for which other administration modes result unsatisfactory or ineffective. More specifically, the invention is directed to such a system having an implanted infusion device provided with an improved docking group for reliably docking an ingestible substance carrier. The invention also relates to a special construction of the carrier.

A medical system for applying negative pressure within a gastrointestinal tract of a subject. The medical system includes an elongate tube defining at least one interior channel, a plurality of orifices in fluid communication with the interior channel, and at least one exterior channel. The exterior channel is in fluid communication with the interior channel via at least one of the orifices. The elongate tube has a delivery state, and a first operative state in which the elongate tube forms a coil including a plurality of loops. A fluid-tight lumen is in fluid communication with the elongate tube. The lumen is adapted to couple to a source of negative pressure for delivery of negative pressure to the elongate tube. In the first operative state of the elongate tube, a length of the coil is at least 15 mm and the plurality of loops includes at least 4 loops.